| 产品描述: | 平滑受体激动剂;Smoothened receptor agonist;Purmorphamine与Smo拮抗剂竞争性结合到Smoothened,并激活Smoothened,IC50约为1.5 μM,也诱导成骨细胞分化,EC50为1μM。;Purmorphamine, which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo with IC50 of ~ 1.5 μM and also is an inducer of osteoblast differentiation with EC50 of 1 μM.An activator of the hedgehog (Hh) signaling pathway. |
| 靶点: |
IC50: 1.5 μM (Smoothened) |
| 参考文献: |
1. Beloti MM, et al. Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells. Cell Biol Int. 2005 Jul;29(7):537-41.. . . . 2. Gu D, et al. A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis. J Biol Chem. 2012 Nov 2;287(45):38356-66. 3. Beloti MM, et al. Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells. Cell Biol Int. 2005 Jul;29(7):537-41. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.921 ml |
9.604 ml |
19.208 ml |
| 5 mM |
0.384 ml |
1.921 ml |
3.842 ml |
| 10 mM |
0.192 ml |
0.96 ml |
1.921 ml |
| 50 mM |
0.038 ml |
0.192 ml |
0.384 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |